PATENT CLAIM ANALYSIS

Application Number: 15887388
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "357000"]

Abstract:
The present disclosure relates to a pharmaceutical composition comprising as active substance betahistine or a pharmaceutically acceptable salt thereof, for use in the treatment of otological or neurological disorders in a human subject by intranasal application.

Claim (Index 87):
The method of  claim 86 , wherein the vestibular disorder is vestibular vertigo or Meniere's disease.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13747367', '14966301', '12221333', '15866787', '15564824']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7961716664029453
- 35 USC 102 Novelty (BERT): 0.5282233015670085
- Combined Prediction Score: 0.7693768299193517
- Mean Citation Score: 280.87664200000006
- Max Citation Score: 304.8288
- Similarity Product: 153.21242814445498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test